3. Materials and Methods
All manipulations were carried out under an atmosphere of inert argon inside glove boxes or by using standard vacuum line techniques. Solvents were dried by literature known procedures [
22] and distilled before use. NMR spectra were recorded on Bruker Avance 250 (
1H 250.0 MHz,
13C 62.9 MHz,
31P 101.2 MHz) or Avance 400 (
1H 400.1 MHz,
13C 100.5 MHz,
31P 161.9 MHz) instruments at 293 K if not stated otherwise.
1H Chemical shifts were referenced to TMS using the signals of the residual protons of the deuterated solvent (δ
1H = 7.15 (C
6D
6), 1.73 (THF-D
8)) as secondary reference. Atoms in pyridine rings were denoted as H-6, 6-C etc. Spectra of heteronuclei were referenced using the Ξ-scale [
23] employing TMS (Ξ = 25.145020 MHz,
13C) and 85 % H
3PO
4 (Ξ = 40.480747 MHz,
31P) as secondary references. Elemental analyses were determined on a Thermo Micro Cube CHN analyzer. Previously known azopyridines were prepared as reported [
9,
14] (data for 1b: yield 58%;
1H NMR (CDCl
3): δ = 2.39 (br s, 3 H, CH
3), 7.15 (dq,
3JHH = 4.9 Hz,
4JHH = 0.8 Hz, 1 H, H-5), 7.42–7.50 (m, 3 H,
m/
p-Ph), 7.57 (m, 1 H, H-3), 7.95 (m, 2 H,
o-Ph), 8.53 (d,
3JHH = 4.9 Hz, 1 H, H-6). –
13C{
1H}-NMR (CDCl
3): δ = 21.5 (CH
3), 116.5 (C-3), 123.9 (
o-Ph), 126.5 (C-5), 129.5 (
m-Ph), 132.4 (
p-Ph), 149.6 (C-6), 150.6 (C-4), 152.9 (
i-Ph), 163.4 (C-2). Chromatography was carried out using silica as stationary phase.
2-t-butylazo-pyridine (1c): Method A: A round-bottom Schlenk flask was charged with 2-aminopyridine (4.50 g, 47.8 mmol), lithium (331 mg, 47.8 mmol), excess t-BuNO (12.5 g, 143 mmol), and Et2O (50 mL). The mixture was stirred for 3 d in the dark. Evaporation of volatiles and purification of the resulting crude product by flash chromatography yielded 1c (4.24 g, 26.0 mmol, 54%) as a yellow oil. Method B: A solution of 2-nitrosopyridine (1.00 g, 9.25 mmol) and t-butylamine (1.09 mL, 765 mg, 10.5 mmol) in degassed methylene chloride (40 mL) was stirred for 24 h in the dark. Evaporation of volatiles from the resulting yellow solution and flash chromatography (eluent petroleum ether/ethyl acetate 9:1) of the residue afforded 1c as a yellow oil (1.28 g, 7.84 mmol, 85%). The products obtained by either method were characterized by 1H and 13C NMR spectroscopy and used as is for further reactions. –1H NMR (CDCl3): δ = 1.33 (s, 9 H, t-Bu), 7.29 (ddd, 3JHH = 7.4 Hz, 4.8 Hz, 4JHH = 1.1 Hz, 1 H, H-5), 7.43 (ddd, 3JHH = 8.0 Hz, 4JHH = 1.1 Hz, 1 H, H-3), 7.77 (ddd, 3JHH = 8.0 Hz, 7.4 Hz, 4JHH = 1.9 Hz, 1 H, H-4), 8.59 (ddd, 3JHH = 4.8 Hz, 4JHH = 1.9 Hz, 5JHH = 1.1 Hz, 1 H, H-6). –13C{1H} NMR (CDCl3): δ = 26.9 (CH3), 69.0 (NC), 114.2 (3-C), 124.7 (5-C), 138.4 (4-C), 149.2 (6-C), 162.8 (2-C).
2-(t-butylazo)-4-methylpyridine (1d): A suspension of LDA (1.87 g, 17.5 mmol) in Et2O (30 mL) was added slowly to a cooled (0 °C) solution of 4-methyl-2-aminopyridine (1.72 g, 15.9 mmol) in Et2O (20 mL). The mixture was warmed to rt, and t-BuNO (3.44 mL, 3.16 g, 36.3 mmol) was added. After 3 d, the reaction mixture was quenched with water (50 mL). The organic layer was separated, washed with water, and dried with brine and then MgSO4. Evaporation of volatiles and purification of the residue by column chromatography (eluent PE/ethyl acetate 1:1) afforded 1d as a yellow oil (422 mg, 2.38 mmol, 15%) that was used as is for further reactions. –1H NMR (CDCl3): δ = 1.33 (s, 9 H, t-Bu), 2.36 (s, 3 H, CH3), 7.10 (dq, 3JHH = 5.0 Hz, 4JHH = 0.8 Hz, 1 H, H-5), 7.23 (m, 1 H, H-3), 8.43 (d, 3JHH = 5.0 Hz, 1 H, H-6). –13C{1H} NMR (CDCl3): δ = 20.1 (CH3), 25.8 (CCH3), 67.8 (CCH3), 113.6 (3-C), 124.6 (5-C), 147.8 (4-C), 148.8 (6-C), 161.9 (2-C).
4-(t-butyl)-2-(t-butylazo)pyridine (1e): A round-bottom Schlenk flask was charged with 4-t-butyl-aminopyridine (3.50 g, 23.3 mmol), Na (535 mg, 23.3 mmol), t-BuNO (5.46 g, 62.7 mmol) and Et2O (ca. 80 mL). The mixture was stirred for 5 d. Water (50 mL) was slowly added. The organic layer of the resulting biphasic system was separated, washed with water, and dried with brine and then MgSO4. Evaporation of volatiles and purification of the residue by column chromatography (eluent PE/ethyl acetate 5:1) afforded 1e as a yellow oil (4.22 g, 19.2 mmol, 82%) that was used as is. –1H NMR (CDCl3): δ = 1.34 (s, 9 H, t-Bu), 1.39 (s, 9 H, t-Bu), 7.31 (dd, 3JHH = 5.3 Hz, 4JHH = 1.8 Hz, 1 H, H-5), 7.47 (d, 4JHH = 1.8 Hz, 1 H, H-3), 8.52 (d, 3JHH = 5.3 Hz, 1 H, H-6). –13C{1H} NMR (CDCl3): δ = 27.3 (CCH3), 30.9 (CCH3), 35.5 (CCH3), 69.2 (NCCH3), 112.3 (3-C), 122.2 (5-C), 149.4 (6-C), 163.3 (2-C or 4-C), 163.5 (2-C or 4-C).
2-(2,6-diisopropylphenyl)azo-pyridine (1f): Nitrosopyridine (2.50 g, 23.1 mmol) and diisopropylaniline (4.10 g, 23.1 mmol) were dissolved in methylene chloride. A few drops of degassed acetic acid were added, and the reaction mixture was stirred in the dark for 3 d. Solvent and catalyst were removed under reduced pressure and the residue was purified by column chromatography to give a red oil (yield 1.11 g, 4.16 mmol, 18%) that was characterized by 1H NMR spectroscopy and used as is for further syntheses. The 1H NMR spectrum displayed additional signals, which were assigned to a second stereoisomer (presumably rotamer or Z-isomer, approx. 17%). –1H NMR (CDCl3): δ = 1.12 (d, 3JHH = 6.9 Hz, 12 H, CH3), 3.09 (sept, 3JHH = 6.9 Hz, 2 H, CH), 7.16 –7.28 (m, 3 H, CHDipp), 7.38 (ddd, 3JHH = 7.5 Hz, 4.8 Hz, 4JHH = 1.2 Hz, 1 H, H-5), 7.68 (d, 3JHH = 7.6 Hz, 1 H, H-3), 7.87 (ddd, 3JHH = 7.5 Hz, 7.6 Hz, 4JHH = 2.0 Hz, 1 H, H-4), 8.70 (ddd, 3JHH = 4.8 Hz, 4JHH = 2.0 Hz, 5JHH = 0.8 Hz, 1 H, H-6).
3-bromo-2-(pyridin-2-yl)-2,3-dihydro-[1,2,4,3]triazaphospholo[4,5-a]pyridine (2a): A round-bottom Schlenk flask was charged with azopyridine 1a (500 mg, 2.71 mmol) and methylene chloride (30 mL). Cyclohexene (668 mg, 8.13 mmol) and PBr3 (807 mg, 2.98 mmol) were subsequently added slowly, and the resulting mixture was stirred for 12 h. Volatiles were removed under reduced pressure. The residue was washed with pentane (20 mL) to furnish 2a (714 mg, 2.42 mmol, 89%) as a yellowish powder whose low solubility in organic solvents precluded its characterization by 13C NMR spectroscopy. –1H NMR (CDCl3): δ = 6.43 (t, 3JHH = 5.9 Hz, 1 H), 6.94–7.16 (m, 3 H), 7.56 –7.83 (m, 3 H), 8.41 (d, 3JHH = 4.6 Hz, 1 H). –31P{1H} NMR (CDCl3): δ = 135.0 (s). C10H8BrN4P (295.08 g/mol), calcd. C 40.70 H 2.73 N 18.99, found C 39.93 H 2.73 N 18.53.
3-bromo-7-methyl-2-phenyl-2,3-dihydro-[1,2,4,3]triazaphospholo[4,5-a]pyridine (2b): The reaction of azopyridine 1b (893 mg, 4.53 mmol), cyclohexene (1.12 g, 13.6 mmol) and PBr3 (1.35 g, 4.98 mmol) was carried out as described for 2a to yield 2b (1.27 g, 4.12 mmol, 91%) as a yellowish solid. –1H NMR (CDCl3): δ = 2.28 (s, 3 H, CH3), 6.36 (dd, 3JHH = 7.2 Hz, 4JHH = 1.4 Hz, 1 H, H-6), 6.95 (m, 1 H, H-8), 7.26 (m, 1 H, p-Ph), 7.44 (m, 2 H, o-Ph), 7.64–7.69 (m, 3 H, m-Ph and H-5). –13C{1H} NMR (CDCl3): δ = 22.1 (d, 5JPC = 0.9 Hz, CH3), 113.4 (d, 3JPC = 0.7 Hz, 8-C), 115.5 (d, 3JPC = 12.6 Hz, 6-C), 120.2 (d, 3JPC = 14.8 Hz, o-Ph), 126.4 (d, 5JPC = 3.1 Hz, p-Ph), 128.4 (d, 2JPC = 14.8 Hz, 5-C), 130.0 (d, 3JPC = 0.6 Hz, m-Ph), 141.4 (d, 2JPC = 9.0 Hz, i-Ph), 143.1 (d, 4JPC = 4.3 Hz, 7-C), 150.0 (d, 2JPC = 11.5 Hz, 9-C). –31P{1H} NMR (CDCl3): δ = 138.6 (s). –C12H11BrN3P (308.12 g/mol): calcd. C 46.78 H 3.60 N 13.64, found C 47.10 H 3.66 N 14.45.
3-bromo-2-(t-butyl)-2,3-dihydro-[1,2,4,3]triazaphospholo[4,5-a]pyridine (2c): The reaction of azopyridine 1c (240 mg, 1.47 mmol), cyclohexene (362 mg, 4.41 mmol, 3 equivs.) and PBr3 (439 mg, 1.62 mmol) in methylene chloride (20 mL) were carried out as described for 2a yielding 2c (344 mg, 1.26 mmol, 86%) as a yellow solid. –1H NMR (CDCl3): δ = 1.68 (d, 4JPH = 1.9 Hz, 9 H, t-Bu), 6.58 (td, 3J = 6.7 Hz, 4J = 0.9 Hz, 1 H, H-2), 7.10 (m, 1 H, H-3), 7.24 (m, 1 H, H-4), 7.89 (m, 1 H, H-1). –13C{1H} NMR (CDCl3): δ = 29.1 (d, 3JPC = 12.0 Hz, CCH3), 60.8 (d, 2JPC = 5.1 Hz, NCCH3), 112.4 (d, 2JPC = 12.1 Hz, 2-C), 116.4 (s, 4-C), 129.4 (d, 2JPC = 14.0 Hz, 1-C), 131.1 (d, 4JPC = 3.5 Hz, 3-C), 149.5 (d, 2JPC = 9.8 Hz, 5-C). –31P{1H} NMR (CDCl3): δ = 154.9 (s). C9H13BrN3P (274.10 g/mol): calcd. C 39.44 H 4.78 N 15.33, found C 38.49 H 4.81 N 14.70.
3-bromo-2-(t-butyl)-7-methyl-2,3-dihydro-[1,2,4,3]triazaphospholo[4,5-a]pyridine (2d): The reaction of azopyridine 1d (240 mg, 1.35 mmol), cyclohexene (343 mg, 4.06 mmol) and PBr3 (402 mg, 1.49 mmol) in methylene chloride (20 mL) and the purification of the crude product was carried out as described for 2a yielding 2d (319 mg, 1.11 mmol, 82%) as a yellow solid. –1H NMR (CDCl3): δ = 1.67 (d, 4JPH = 1.8 Hz, 9 H, t-Bu), 2.27 (s, 3 H, CH3), 6.45 (dd, 3JHH = 7.2 Hz, 4JPH = 1.3 Hz, 1 H, H-6), 7.05 (s, 1 H, H-8), 7.81 (dd, 3JHH = 7.2 Hz, 3JPH = 4.1 Hz, 1 H, H-5). –13C{1H} NMR (CDCl3): δ = 22.0 (CH3), 29.4 (d, 3JPC = 12.0 Hz, CCH3), 61.1 (d, 2JPC = 5.0 Hz, NCCH3), 113.9 (s, 8-C), 116.2 (d, 3JPC = 11.9 Hz, 6-C), 129.0 (d, 2JPC = 14.1 Hz, 5-C), 143.3 (br, 7-C), 150.5 (2JPC = 10.0 Hz, 9-C). –31P{1H} NMR (CDCl3): δ = 154.6 (s). –C10H15BrN3P (288.13 g/mol): calcd. C 41.69 H 5.25 N 14.58, found C 38.86 H 4.94, N 13.07.
3-Bromo-2,7-di-t-butyl-2,3-dihydro-[1,2,4,3]triazaphospholo[4,5-a]pyridine (2e): The reaction of 1e (3.50 g, 16.0 mmol), cyclohexene (3.94 g, 48.0 mmol) and PBr3 (4.76 g, 17.6 mmol) in methylene chloride (100 mL) and the purification of the crude product was carried out as described for 2a yielding 2e (4.14 g, 12.5 mmol, 78%) as a yellow solid. –1H NMR (CDCl3): δ = 1.26 (s, 9 H, 7-t-Bu), 1.67 (d, 4JPH = 1.3 Hz, 9 H, 2-t-Bu), 6.65 (dd, 3JHH = 7.5 Hz, 4JPH = 1.7 Hz, 1 H, H-6), 7.13 (br s, 1 H, H-8), 7.86 (ddd, 3JHH = 7.5 Hz, 3JPH = 4.0 Hz, 5JHH = 0.7 Hz, 1 H, H-5). –13C{1H} NMR (CDCl3): δ = 29.1 (d, 3JPC = 12.1 Hz, NCCH3), 29.5 (s, CCH3), 35.2 (s, CCH3), 60.8 (d, 2JPC = 5.0 Hz, NCCH3), 110.0 (s, 6-C), 112.6 (d, 3JPC = 11.8 Hz, 8-C), 128.6 (d, 2JPC = 13.5 Hz, 5-C), 150.6 (d, 2JPC = 10.0 Hz, 9-C), 155.0 (d, 4JPC = 3.5 Hz, 7-C). –31P{1H} NMR (CDCl3): δ = 156.4. –C13H21BrN3P (330.21 g/mol): calcd. C 47.29 H 6.41 N 12.73, found C 46.88 H 6.46 N 12.66.
3-Bromo-2-(2,6-diisopropylphenyl)-2,3-dihydro-[1,2,4,3]triazaphospholo[4,5-a]py ridine (2f): The reaction of 1e (780 mg, 2.92 mmol), cyclohexene (720 mg, 8.76 mmol,) and PBr3 (869 mg, 3.21 mmol) in methylene chloride (30 mL) was carried out as described for 2a yielding 2f (530 mg, 1.40 mmol, 48%) as a brownish solid. –1H NMR (CDCl3): δ = 1.18 (d, 3JHH = 6.8 Hz, 6 H, CH3), 1.26 (d, 3JHH = 6.8 Hz, 6 H, CH3), 2.94 (sept, 3JHH = 6.8 Hz, 2 H, CH), 6.63 (dddd, 3JHH = 7.2, 6.4 Hz, 4JHH = 1.2 Hz, 4JPH = 0.6 Hz, 1 H, H-6), 7.15 (dddd, 3JHH = 9.5, 6.4 Hz, 4JHH = 1.3 Hz, 5JPH = 1.3 Hz, 1 H, H-7), 7.24 (dddd, 3JHH = 9.5 Hz, 4JHH = 1.3 Hz, 5JHH = 1.2 Hz, 6JPH = 2.8 Hz, 1 H, H-8), 7.28 (dd, 3JHH = 7.7 Hz, 5JPH = 0.5 Hz, 2 H, CH), 7.94 (dddd, 3JHH = 7.2 Hz, 4JHH = 1.3 Hz, 5JHH = 1.3 Hz, 3JPH = 4.7 Hz, 1H, H-5). –13C{1H} NMR (CDCl3): δ = 24.5 (d, 5JPC = 1.9 Hz, CH3), 24.8 (s, CH3), 28.7 (CH), 112.0 (d, 3JPC = 12.1 Hz, 7-C), 116.0 (8-C), 124.3 (d, 4JPC = 1.2 Hz, m-Ph), 129.8 (d, 2JPC = 12.1 Hz, 5-C), 130.2 (d, 5JPC = 1.9 Hz, p-Ph), 131.4 (d, 4JPC = 3.8 Hz, 7-C), 133.3 (d, 3JPC = 7.1 Hz, i-Ph), 147.5 (d, 2JPC = 6.4 Hz, o-Ph), 149.0 (d, 2JPC = 12.1 Hz, 9-C). –31P{1H} NMR (CDCl3): δ = 150.5. –C17H21BrN3P (378.25 g/mol): calcd. C 53.98 H 5.60 N 11.11, found C 53.27 H 5.81 N 10.80.
3-Iodo-2-(pyridin-2-yl)-2,3-dihydro-[1,2,4,3]triazaphospholo[4,5-a]pyridine (3a): A solution of PI3 (658 mg, 1.60 mmol) in methylene chloride (17 mL) was added dropwise to a solution of 1a (300 mg, 1.63 mmol) in methylene chloride (10 mL). The mixture was stirred for 12 h. Volatiles were removed under reduced pressure and the red residue was washed with pentane. Recrystallization from pyridine furnished 3a as red crystals (224 mg, 656 μmol, 41%). –1H NMR (THF-d8): δ = 6.68 (t, 3JHH = 6.5 Hz, 1 H, H-7), 7.11–7.23 (m, 2 H, H-8 and m-H), 7.73 (d, 3JHH = 8.0 Hz, 1 H, m-H), 7.86 (t, 3JHH = 8.0 Hz, 1 H, p-H), 7.95–8.04 (m, 1 H, H-6), 8.44 (d, 3JHH = 4.8 Hz, 1 H, o-H), 8.92 (d, 3JHH = 5.3 Hz, 1 H, H-5). –31P{1H} NMR (THF-d8): δ = 161.6 (s). –C10H8IN4P (342.08 g/mol): calcd. C 35.11 H 2.39 N 16.38, found C 35.26 H 2.57 N 15.99.
2-(t-butyl)-3-methyl-2,3-dihydro-[1,2,4,3]triazaphospholo[4,5-a]pyridine (4): A 1.6 M solution of MeLi in Et2O (1.37 mL, 2.19 mmol) was slowly added at -78 °C to a solution of 2c (600 mg, 2.19 mmol) in THF (25 mL). After the addition was complete, the solution was allowed to ambient temperature. Volatiles were removed under reduced pressure and the residue was distilled under vacuum (bp. 54 °C, 10−3 mbar) to afford a dark yellow, highly air-sensitive oil that eventually solidified upon standing (yield 250 mg, 1.19 mmol, 54%). –1H NMR (CDCl3): δ = 0.88 (d, 2JPH = 7.2 Hz, 3 H, CH3), 1.30 (d, 4JPH = 1.0 Hz, 9 H, t-Bu), 5.66 (dddd, 3JHH = 7.2, 5.7 Hz, 4JHH = 0.4 Hz, 4JPH = 2.1 Hz, 1 H, H-6), 6.50 (dddd, 3JHH = 9.8, 4JHH = 1.3 Hz, 5JHH = 0.4 Hz, 6JPH = 1.0 Hz, 1 H, H-7), 6.54 (dddd, 3JHH = 9.8, 5.7 Hz, 4JHH = 1.3 Hz, 5JPH = 0.3 Hz, 1 H, H-8), 6.98 (dddd, 3JHH = 7.2 Hz, 4JHH = 2.1 Hz, 5JHH = 1.3 Hz, 3JPH = 4.6 Hz, 1H, H-5). –13C{1H} NMR (CDCl3): δ = 20.7 (d, 1JPC = 37.7 Hz, CH3), 29.6 (d, 3JPC = 9.8 Hz, CCH3), 56.0 (s, NCCH3), 105.4 (d, 3JPC = 6.5 Hz. 6-C), 114.3 (s, 8-C), 131.0 (d, 4JPC = 1.5 Hz, 7-C), 131.3 (s, 5-C), 149.0 (s, 9-C). –31P{1H} NMR (CDCl3): δ = 88.4 (s). –C10H16PN3 (209.23 g/mol): calcd. C 57.40 H 7.71 N 20.08, found C 58.12 H 8.22 N 20.22.
Bis-{2-(t-butyl)-3-methyl-2,3-dihydro-[1,2,4,3]triazaphospholo[4,5-a]pyridine}-{1,5-cyclooctadiene}-nickel(0) (5): Addition of a solution of 4 (76 mg, 0.363 mmol) in THF (10 mL) to a solution of Ni(COD)2 (50 mg, 0.182 mmol) in THF (7 mL) immediately produced a deep red solution. After stirring for an additional 2 h, the solvent was removed under reduced pressure, the residue suspended in hexane, and filtrated over celite. Storage of the filtrate at −28 °C for 1 week produced a crystalline material identified as a diastereomeric mixture of rac- and meso-5 (yield 62 mg, 0.106 mmol, 58%). Manual selection furnished a crystal of rac-5 suitable for a single-crystal XRD study. –1H NMR (C6D6): major diasteromer (80%): δ = 1.30 (s, 6 H, CH3), 1.49 (s, 18 H, t-Bu), 1.95 (m, 2 H, CH2), 2.13 (m, 2 H, CH2), 2.29 (m, 2 H, CH2), 2.43 (m, 2 H, CH2), 4.50 (m, 4 H, =CH), 5.22 (t, 3JHH = 6.4 Hz, 2 H, H-7), 5.92 (ddd, 2 H, 3JHH = 9.7, 6.2 Hz, 4JHH = 1.0 Hz, H-6), 6.27 (d, 1 H, 3JHH = 9.6 Hz, H-8), 6.60 (br m, 1 H, H-5); minor diastereomer: δ = 1.36 (s, 6 H, CH3), 1.43 (s, 18 H, t-Bu), 2.15 (m, 4 H, CH2), 2.29 (m, 4 H, CH2), 4.37 (m, 2 H, =CH), 4.67 (m, 2 H, =CH), 5.24 (t, 3JHH = 6.4 Hz, 2 H, H-7), 5.97 (ddd, 2 H, 3JHH = 9.7, 6.2 Hz, 4JHH = 1.0 Hz, H-6), 6.29 (d, 1 H, 3JHH = 9.6 Hz, H-8), 6.78 (br m, 1 H, H-5). –13C{1H} NMR (C6D6): major diastereomer: δ = 23.3 (m, CH3), 29.3 (m, CH2), 31.0 (CCH3), 32.9 (m, CH2), 56.6 (NCCH3), 88.2 (br, =CH), 89.0 (br, =CH), 105.1 (m, 7-C), 116.4 (8-C), 129.0 (s, 6-C), 130.5 (m, 5-C), 145.2 (9-C); minor diastereomer: δ = 23.9 (m, CH3), 30.8 (m, CH2), 31.0 (m, CCH3), 29.3 (m, CH2), 31.0 (m, CCH3), 56.9 (NCCH3), 87.4 (br, =CH), 87.9 (br, =CH), 104.9 (m, 7-C), 116.39 (8-C), 129.2 (s, 6-C), 131.1 (m, 5-C), 145.4 (9-C). –31P{1H} NMR (C6D6): δ = 131.0 (major diastereomer, 80%), 132.3 (minor diastereomer, 20%).
Crystallographic Studies. Single-crystal X-ray diffraction data were measured on a Bruker Kappa APEX2 Duo diffractometer at 135(2) K for 3a and 2f, 140(2) K for 2c-e, and 145(2) K for 4 and 5, respectively, using Cu-Kα radiation (
= 1.54178 Å) for 5 and Mo-
radiation (
= 0.71073 Å) for the remaining compounds. The structures were solved by direct methods (SHELXS-2014 [
24]) or dual space/intrinsic methods (SHELXT [
25]) and refined with a full-matrix-least-squares scheme on
F2 (SHELXL-2014 [
24]). Semi-empirical absorption corrections from equivalents were applied for
2c–
f and
4, and numerical absorption corrections for
3a,
5. Nonhydrogen atoms were refined anisotropically. The Br-atom of
2f was disordered over two positions and was refined using restraints, and
2d was refined as a 2-component twin, BASF = 0.251 (
5). Further crystallographic data and details on the structure solution are given in the
Supplementary Material. CCDC 2183389 (
3a), 2183390 (
2f), 2183391 (
2c), 2183392 (
2e), 2183393 (
2d), 2183394 (
4), and 2183395 (
5) contain the crystallographic data for this paper, which can be obtained free of charge from the Cambridge Crystallographic Data Centre via
www.ccdc.cam.ac.uk/data_request/cif (accessed on 13 July 2022).